pubrio
Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited

Australia · Pharmaceutical Manufacturing

Medical Devices

Pharmaceuticals

Biotechnology

Pharmaceutical Manufacturing

Telix is a biopharmaceutical company focused on the development and commercialisation of therapeutic and diagnostic ('theranostic') radiopharmaceuticals. Telix is headquartered in Melbourne, Australia with commercial operations in the United States, Europe (Belgium and Switzerland) and Japan. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).

Company Insights
Company Overview

2016

Founded

Pharmaceutical Manufacturing

Industry

Australia

Location

1,604,285

Ranking

600 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Telix Pharmaceuticals Limited

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​